Raymond James Financial
ETON icon

Raymond James Financial’s Eton Pharmaceutcials ETON Stock Holding History

Raymond James Financial’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$302K Hold
12,250
– – ﹤0.01% 4651
2025
Q4 		$207K Sell
12,250
-74,832
-86% -$1.32M ﹤0.01% 4773
2025
Q3 		$1.89M Sell
87,082
-3,333
-4% -$55.3K ﹤0.01% 3214
2025
Q2 		$1.29M Buy
90,415
+12,202
+16% +$193K ﹤0.01% 3403
2025
Q1 		$1.02M Buy
78,213
+67,170
+608% +$1.01M ﹤0.01% 3481
2024
Q4 		$147K Buy
+11,043
New +$112K ﹤0.01% 4470

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return

Raymond James Financial's ETON Position: Q1 2026 in Review

Raymond James Financial held its Eton Pharmaceutcials (ETON) position steady in Q1 2026 at 12,250 shares worth $302K. The position accounts for ﹤0.01% of the portfolio, ranked #4651.

Raymond James Financial first reported a position in ETON in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.89M in Q3 2025. 116 funds tracked by Wall St. Rank hold ETON as of Q1 2026.

  • Raymond James Financial held 12,250 shares of Eton Pharmaceutcials worth $302K as of Q1 2026.
  • Raymond James Financial left its Eton Pharmaceutcials share count unchanged in Q1 2026.
  • Eton Pharmaceutcials made up ﹤0.01% of Raymond James Financial's portfolio in Q1 2026, its #4651 holding.
  • Raymond James Financial first reported a position in Eton Pharmaceutcials in Q4 2024 and has held it in 6 quarters since.
  • Raymond James Financial's Eton Pharmaceutcials position peaked at $1.89M in Q3 2025.
  • 116 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.